SIRT1 overexpression by melatonin and resveratrol combined treatment attenuates premature ovarian failure through activation of SIRT1/FOXO3a/BCL2 pathway
Biochemical and Biophysical Research Communications · 2024-02 · 696 · 149506
DOI: 10.1016/j.bbrc.2024.149506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-02. Verfasst von Kubra Sevgin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, International Faculty of Medicine, University of Health Sciences, Istanbul 34668, Turkey. Electronic address:…. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Melatonin. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Sağlık Bilimleri Üniversitesi.
Abstract (Originalsprache)
AIM: To evaluate the synergistic effect of combined treatment with melatonin (MEL) and resveratrol (RES) in cisplatin (CIS)-induced premature ovarian failure (POF) model in rats and to elucidate the molecular mechanism of this therapeutic effect. MATERIAL & METHODS: Female Sprague Dawley rats were divided into 7 experimental groups as follows; CONT (Control), CIS, MEL, RES, POF + MEL, POF + RES, and POF + MEL + RES. H&E staining was performed to evaluate follicular cell vacuolization/degeneration, vascular congestion/hemorrhage, and inflammation, by using an ordinal scale from 0 to 4 to grade the severity of observed changes (0 = normal, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe). Zona pellucida integrity and connective tissue amount in the ovarian tissue were detected using PAS & Masson Trichrome staining. The immunofluorescence method was used to determine the immune localizations of pH2Ax, SIRT1, FOXO3a, and BCL2. The connective tissue amounts and immunoreactivity staining intensities were measured using ImageJ. The gene expression of SIRT1, FOXO3a, and BCL2 was determined using RT-PCR. Serum estrogen hormone levels were measured by ELISA. Statistically, Bonferroni correction was performed, and p < 0.002 were considered significant. RESULTS: A significant difference was observed in the POF group compared to the CONT group in all parameters except tertiary follicle count and hemorrhage. The decrease in the number of atretic follicles in the POF + MEL + RES group was found significant compared to both POF + MEL and POF + RES groups. The expression of pH2Ax, SIRT1, FOXO3a, and BCL2 at the protein level and SIRT1 and BCL2 at the mRNA level were significant in the POF + MEL + RES group compared to the POF group. Between the single and combination treatment groups, the difference in protein level was found in pH2Ax, SIRT1, FOXO3a, and BCL2 expression. The POF + MEL + RES group exhibited significantly higher SIRT1 mRNA expression compared to the groups receiving single treatments. CONCLUSION: The present study provides evidence that MEL and RES have synergistic effects in preventing the decrease in follicle reserve and increase in DNA break (pH2Ax) and follicle atresia in POF ovaries. This therapeutic effect is mediated by SIRT1 overexpression and activation of the SIRT1/FOXO3a/BCL2 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, International Faculty of Medicine, University of Health Sciences, Istanbul 34668, Turkey. Electronic address: kubra.sevgin@sbu.edu.tr.
- Department of Histology and Embryology, International Faculty of Medicine, University of Health Sciences, Istanbul 34668, Turkey.
Förderung
- Sağlık Bilimleri Üniversitesi
Zitieren
APA
Sevgin, K., & Erguven, P. (2024). SIRT1 overexpression by melatonin and resveratrol combined treatment attenuates premature ovarian failure through activation of SIRT1/FOXO3a/BCL2 pathway. Biochemical and Biophysical Research Communications, 696, 149506. https://doi.org/10.1016/j.bbrc.2024.149506
Vancouver
Sevgin K, Erguven P. SIRT1 overexpression by melatonin and resveratrol combined treatment attenuates premature ovarian failure through activation of SIRT1/FOXO3a/BCL2 pathway. Biochemical and Biophysical Research Communications. 2024;696:149506. doi:10.1016/j.bbrc.2024.149506
BibTeX
@article{Sevgin2024,
author = {Sevgin, Kubra and Erguven, Pelin},
title = {SIRT1 overexpression by melatonin and resveratrol combined treatment attenuates premature ovarian failure through activation of SIRT1/FOXO3a/BCL2 pathway},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {696},
pages = {149506},
doi = {10.1016/j.bbrc.2024.149506}
}
EUVIMED